MedTrace Logo

Intracervical Block Versus Placebo to Assess Pain Control During Hysterosalpingogram

NCT00372658 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2006-09-07

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of 1% lidocaine intracervical block to placebo for pain control during the performance of a hysterosalpingogram (HSG). We hypothesized that an intracervical block would decrease pain during a hysterosalpingogram.

Conditions

Interventions

DRUG

1% Lidocaine intracervical injection

Sponsors & Collaborators

  • 59th Medical Wing

    lead FED

Principal Investigators

  • Randal D Robinson, MD · Wilford Hall Medical Center and Brooke Army Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-07-31
Completion
2004-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00372658 on ClinicalTrials.gov